Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × Patient Reported Outcome Measures × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 513 Bevacizumab 486 Carboplatin 419 Paclitaxel 382 pembrolizumab 372 Gemcitabine 366 Cisplatin 361 Docetaxel 320 Rituximab 314 Radiotherapy 294 Doxorubicin 240 Nivolumab 236 Dexamethasone 236 Fluorouracil 223 Capecitabine 214 Oxaliplatin 210 Erlotinib Hydrochloride 205 fludarabine phosphate 200 Etoposide 187 Cetuximab 181 Lenalidomide 176 Bortezomib 173 Pemetrexed 172 Trastuzumab 170 Filgrastim 170 fludarabine 166 Leucovorin 164 Cytarabine 164 Prednisone 163 Irinotecan 160

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04272801 2025-10-22

POWER

University of Virginia

Phase 2 Active not recruiting

84 enrolled 9 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡